Valeant eyes smaller deals to build on Salix, Dendreon purchases

Laval, Quebec-based Valeant announced the $10.1 billion cash offer for Salix, known for its drug Xifaxan to treat irritable bowel syndrome, on Sunday. Shares of Salix dipped 1.2 percent to $155.90.



via Health News Headlines - Yahoo News http://ift.tt/1D3b7Zl